Last Updated on July 2, 2025
A leaked memo surfaced outlining a plot to remove US Secretary of Health and Human Services Robert F. Kennedy, Jr.
The document, linked to the Biotechnology Innovation Organization (BIO), details a $2 million effort. BIO includes major firms like Pfizer and Merck. The plan targets Kennedy’s regulatory reforms, aiming to oust him by September.
Leaked Memo Allegations
The memo, dated April 3, 2025, suggests BIO held a “Vaccine Policy Steering Committee” meeting.
It claims the group seeks to undo Kennedy’s Senate confirmation. BIO allegedly plans to lobby Congress to push Kennedy out.
The document lacks public authentication from named parties. Whistleblowers provided it to Popular Rationalism for analysis.
The document opens with a blunt political calculation: Kennedy’s candidacy threatens investor confidence, regulatory predictability, and the long-term viability of the vaccine business. BIO leadership in the apparent leaked document states plainly: “It is time to go to The Hill and lobby that it is time for RFK Jr to go.” —[Brownstone Institute]
Campaign Strategy
BIO allocated $2 million—half its cash reserve—for a campaign called “Why We Vaccinate.” This RFK Removal Plot uses fear-based messaging to influence public and legislative views.
The memo names Dr. Mehmet Oz, former Senator Richard Burr, and Senator Bill Cassidy as potential allies. These figures may lend credibility to BIO’s efforts to neutralize Kennedy’s reforms.
Social Media Reaction
The leak sparked outrage on X. Children’s Health Defense posted on July 1, 2025, highlighting the memo.
EXPOSED: The Plot to Get RFK
“On the eve before the US Senate reconvenes, a detailed SECRET trade-association memo plotting the removal of @SecKennedy has leaked. It reads like a coup attempt against regulatory reform—and they are spending millions to make sure… https://t.co/GVlq3dvC1A pic.twitter.com/TeiMjNQ8Uh
— Children’s Health Defense (@ChildrensHD) July 1, 2025
The post warns of strategic division among MAHA supporters, aligning with the memo’s tactics.
Financial and Regulatory Concerns
BIO fears Kennedy’s push for liability and safety data threatens its profit model. The memo cites investor flight due to Kennedy’s “unpredictability.”
Vaxcyte COO Jim Wassil reportedly noted investors are waiting for new data. This reflects BIO’s concern over losing regulatory shortcuts from Operation Warp Speed.
BIO’s own admissions reveal the true motive behind this campaign: fear. Not of disease, but of regulatory disruption. With RFK, Jr. and Commissioner Makary and team tightening standards, BIO executives are alarmed that predictable, post-market surveillance standards are expected to be enforced—and with them, the rapid market influence leverage built during Operation Warp Speed. —[Brownstone Institute]
Timeline and Implications
The memo targets September 2025, when Congress reconvenes and schools reopen. This timing aligns with budget talks and political cycles.
BIO aims to discredit Kennedy before he gains more influence. The plot suggests a broader agenda, including WHO treaty pressures and AI censorship, impacting global health policy.
Public Health Impact
Kennedy’s reforms demand safety testing and data transparency. BIO’s response avoids scientific debate, focusing on narrative control.
The $2 million campaign seeks to protect industry dominance over public health. This effort highlights tensions between corporate interests and American citizens in the MAHA movement.
